Dr. Pederson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
A80
Cleveland, OH 44195Phone+1 216-444-3052
Summary
- Dr. Holly Pederson is an internist in Cleveland, OH and is affiliated with Cleveland Clinic. She received her medical degree from University of California (San Francisco) School of Medicine and has been in practice 29 years. Dr.Pederson is the Director of the Medical Breast Program at Cleveland Clinic and Associate Professor of Medicine at CCLCM. She completed a clinical genetics fellowship at CCF in 2008 and the City of Hope Course in 2017. She is actively involved in clinical research and is co-appointed in the Lerner Research Institute. She has served on the NCCN Risk Reduction and Breast Cancer Genetic Committees and speaks nationally and internationally with a focus on management of high risk patients. She has developed an internal fellowship for training of Medical Breast Providers, a program which she helped to create.
She has more than 35 publications and over 500 citings.
Education & Training
- University of California (San Francisco)Residency, Internal Medicine, 1989 - 1991
- University of California (San Francisco)Internship, Internal Medicine, 1988 - 1989
- University of California San Francisco School of MedicineClass of 1988
Certifications & Licensure
- CA State Medical License 1990 - Present
- OH State Medical License 1994 - 2026
- FL State Medical License 2014 - 2022
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Publications & Presentations
PubMed
- 46 citationsManagement of Genitourinary Syndrome of Menopause in Female Cancer Patients: A Focus on Vaginal Hormonal TherapyKatie K. Crean-Tate, Stephanie S. Faubion, Holly J. Pederson, Jennifer A. Vencill, Pelin Batur
American Journal of Obstetrics and Gynecology. 2020-02-01 - 578 citationsGenetic/familial high-risk assessment: Breast, ovarian, and pancreatic, version 2.2021Mary B. Daly, Tuya Pal, Michael Berry, Saundra S. Buys, Patricia I. Dickson
Journal of the National Comprehensive Cancer Network. 2021-01-06 - 2 citationsRacial disparities in breast cancer risk factors and risk management.Holly J Pederson, Zahraa Al-Hilli, Allison W Kurian
Maturitas. 2024-06-01
Press Mentions
- Northeast Ohio Doctors React to New FDA Mammogram GuidelinesMarch 10th, 2023
- 2021’s Top Stories About Breast, Cervical and Ovarian Cancer ResearchDecember 29th, 2021
- Refining Personalized Breast Cancer Risk AssessmentJune 30th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: